Your browser doesn't support javascript.
loading
Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.
Roels, Juliette; Thénoz, Morgan; Szarzynska, Bronislawa; Landfors, Mattias; De Coninck, Stien; Demoen, Lisa; Provez, Lien; Kuchmiy, Anna; Strubbe, Steven; Reunes, Lindy; Pieters, Tim; Matthijssens, Filip; Van Loocke, Wouter; Erarslan-Uysal, Büsra; Richter-Pechanska, Paulina; Declerck, Ken; Lammens, Tim; De Moerloose, Barbara; Deforce, Dieter; Van Nieuwerburgh, Filip; Cheung, Laurence C; Kotecha, Rishi S; Mansour, Marc R; Ghesquière, Bart; Van Camp, Guy; Berghe, Wim Vanden; Kowalczyk, Jerzy R; Szczepanski, Tomasz; Davé, Utpal P; Kulozik, Andreas E; Goossens, Steven; Curtis, David J; Taghon, Tom; Dawidowska, Malgorzata; Degerman, Sofie; Van Vlierberghe, Pieter.
Afiliação
  • Roels J; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Thénoz M; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Szarzynska B; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Landfors M; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • De Coninck S; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Demoen L; Department of Medical Biosciences, Umeå University, Umeå, Sweden.
  • Provez L; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Kuchmiy A; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Strubbe S; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Reunes L; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Pieters T; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Matthijssens F; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Van Loocke W; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Erarslan-Uysal B; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
  • Richter-Pechanska P; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
  • Declerck K; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Lammens T; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • De Moerloose B; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Deforce D; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Van Nieuwerburgh F; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Cheung LC; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Kotecha RS; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Mansour MR; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Ghesquière B; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, and Hopp Children's Cancer Center at NCT Heidelberg, Heidelberg, Germany.
  • Van Camp G; Molecular Medicine Partnership Unit (MMPU), European Molecular Biology Laboratory (EMBL), University of Heidelberg, Heidelberg, Germany.
  • Berghe WV; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, and Hopp Children's Cancer Center at NCT Heidelberg, Heidelberg, Germany.
  • Kowalczyk JR; Molecular Medicine Partnership Unit (MMPU), European Molecular Biology Laboratory (EMBL), University of Heidelberg, Heidelberg, Germany.
  • Szczepanski T; Laboratory of Protein Chemistry, Proteomics and Epigenetic Signaling (PPES) and Integrated Personalized and Precision Oncology Network (IPPON), Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Davé UP; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Kulozik AE; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Goossens S; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Curtis DJ; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Taghon T; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
  • Dawidowska M; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
  • Degerman S; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia.
  • Van Vlierberghe P; School of Pharmacy and Biomedical Sciences, Curtin University, Perth, Western Australia.
Blood Cancer Discov ; 1(3): 274-289, 2020 11.
Article em En | MEDLINE | ID: mdl-33179015
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Timócitos Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Timócitos Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica